IGC PHARMA, INC. Cash and Restricted Cash
IGC PHARMA, INC. (IGC) had Cash and Restricted Cash of $331.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $331.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $207.00K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $900.00K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $331.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $207.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $900.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $454.00K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $405.00K 10-Q · filed 2026-05-15 |
| 2024-12-31 | $470.00K 10-Q · filed 2026-08-14 |
| 2024-09-30 | $1.55M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $1.82M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $1.20M 10-KT · filed 2026-03-18 |
| 2023-12-31 | $1.38M 10-Q · filed 2025-02-14 |
| 2023-09-30 | $3.03M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $1.72M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $3.20M 10-K · filed 2025-06-27 |
| 2022-12-31 | $4.95M 10-Q · filed 2024-02-14 |
| 2022-09-30 | $6.62M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $8.05M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $10.46M 10-K · filed 2024-06-24 |
| 2021-12-31 | $11.94M 10-Q · filed 2023-02-14 |
| 2021-09-30 | $14.40M 10-Q · filed 2022-11-01 |
| 2021-06-30 | $13.32M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $14.55M 10-K · filed 2023-07-07 |
| 2020-03-31 | $7.26M 10-K · filed 2022-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |